Geneticists Getting Close to Engineering Good Looks
By Lee Dye,
ABC News
| 06. 01. 2005
Just a few years ago most scientists thought that the technical barriers to eliminating some inheritable diseases and producing designer babies through genetic engineering would keep that technology on the back burner for decades, if not centuries.
But a new report out of The Genetics & Public Policy Center at Johns Hopkins University points to recent developments that could "catapult us over what were understood to be the principal technical obstacles" to changing the genetic code so that future generations would be free from the threat of certain diseases. Or perhaps bigger and stronger. Or smarter. Or prettier.
It's called "human germline genetic modification." Germline comes from the word germination, and it means the seed, or the egg, and the various processes that begin a new life. It is different from somatic genetic engineering, which seeks to alter or replace genes in a person with a disease. That alteration is not passed on to the offspring, whereas germline changes will affect all future generations of the altered embryo.
It's similar to cloning, but it has received far less public scrutiny...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...